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Atherothromboembolism  and  intracranial  small  vessel  disease  are  considered  to  be  the  main  causes  of 
cerebrovascular injury, which may lead to cognitive impairment and vascular dementia (VaD). VaD appears to be 
the second most common type of dementia with prevalence estimates of 10-15%. Cortical or multi-infarct dementia 
and subcortical vascular dementia (SVD) are suggested to be the two main forms of VaD. The main clinical features 
of SVD comprise decreased motor performance, early impairment of attention and executive function with slowing 
of information processing. SVD results from lacunar infarcts or multiple microinfarcts in the basal ganglia, thalamus, 
brainstem and white matter and are associated with more than 50% of the VaD cases. White matter changes 
including regions of incomplete infarction are usually widespread in VaD but their contribution to impairment of 
subcortical regions is unclear. While most of VaD occurs sporadically only a small proportion of cases bear clear 
familial traits. CADASIL is likely the most common form of hereditary VaD, which arises from subcortical arteriopathy. 
SVD needs unambiguous definition to impact on preventative and treatment strategies, and critical for selective 
recruitment to clinical trials.
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INTRODUCTION
About a century ago Alois Alzheimer and Emil 
Kraeplin among other neuropsychiatrists had ascribed 
arteriosclerotic dementia resulting from gradual strangu-
lation of the blood supply to the brain as the main cause 
of dementia.
1 Otto Binswanger should be recognized for 
introducing the notion of subclasses of vascular 
dementia (VaD). He described subcortical arteriosclerotic 
encephalopathy upon pathological verification of cerebral 
white matter disorder in a group of eight patients.
1 
Currently we accept that cerebrovascular disease causes 
the second most common form of age-related dementia. 
VaD can, however, result from all forms of cerebrovas-
cular lesions that include post-stroke syndromes.
2 The 
challenge of defining the pathological substrates of VaD 
is complicated by the heterogeneous nature of cerebro-
vascular disease and co-existence of other pathologies 
including Alzheimer type of lesions. Blood vessel size, Journal of Clinical Neurology: Vol. 2, No. 1, 2006
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∙Large vessel dementia (multiple infarcts)
∙Small vessel dementia (small vessel disease and 
microinfarction)
∙Strategic infarct dementia (infarcts in strategic locations)
∙Hypoperfusive dementia
∙Dementia related to angiopathies (hypertension, amyloid)* 
∙Haemorrhagic dementia 
∙Other causes of VaD (vasculitis)
∙Hereditary VaD (CADASIL, CARASIL, HERNS)
Hereditary forms of cerebral amyloid angiopathy involving 
ischaemic strokes and intracerebral haemorrhages may also lead 
to cognitive impairment and stroke. 
CADASIL, cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leukoencephalopathy; CARASIL, cerebral 
autosomal recessive arteriopathy with subcortical infarcts and 
leukoencephalopahty; HERNS, hereditary endotheliopathy, 
retinopathy, nephropathy and stroke.
77 
Table 1. VaD subtypes defined by  blood vessel size and patho-
logical process
origin of vascular occlusion and genetic factors are 
critical factors in defining subtypes of VaD (Table 1). 
Multi-infarct dementia is caused by large vessel disease 
whereas Binswanger type of VaD involving subcortical 
regions including the white matter results from small 
vessel changes. Subcortical ischaemic VaD appears the 
most significant subtype of VaD.
3 Other factors that may 
define the subtype and degree of impairment include 
multiplicity, size, anatomical location, laterality and age 
of the lesion. For the purposes of prevention strategies 
and treatments it is imperative to recognise subtypes of 
VaD yet not devise numerous categories to make the 
task unnecessarily complicated.
4 
DIAGNOSTIC CRITERIA: 
VaD VERSUS MIXED DEMENTIA
There is now a general consensus that the clinical 
diagnosis of VaD in demented patients with evidence of 
cerebrovascular lesions applies only when other causes 
of dementia are ruled out.
5 The diagnosis of VaD 
continues to be a challenge in the face of pathological 
outcomes (Fig. 1). As with diagnosis of other causes of 
A. Clinical diagnosis
B. Pathological outcomes
Figure 1. Overlap of VaD and AD. Clinical diagnosis (A) 
criteria predict overlap of 20-30% whereas autopsy findings (B)
suggest a greater overlap where cases with mixed pathologies 
including cerebrovascular lesions and Alzheimer pathology up to 
Braak stage V are frequent. Several studies suggest this to be 
particularly true in the oldest old (i.e. >85 years old). 
dementia criteria may be derived from a range of 
investigations including a detailed clinical history, timing 
of event, neuropsychometric tests, neuroimaging and 
neuropathological reports in accord with the DSM 
criteria. Since the 1970s several clinical criteria for VaD 
have been put forward.
5-7 Historically all the criteria 
have largely adopted the Alzheimer type disease model 
despite the fact that vascular cognitive impairment (VCI) 
or VaD is a cluster of clinical syndromes related to 
complex interactions between cerebrovascular disease 
(CVD), vascular risk factors, brain changes and host 
factors. The widely used criteria for VaD include the 
DSM-IV,
8 the ICD-10,
9 the ADDTC criteria
10 and the 
NINDS-AIREN criteria.
4 The two cardinal elements 
implemented in the clinical criteria for VaD are the Kalaria RN and Erkinjuntti T. Cerebral Small Vessel Disease 
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nature of the cognitive syndrome
11 and the type of 
vascular injury in the cause of the dementia.
5,7,12 
Variation in definitions of these two elements has 
resulted in different prevalence estimates, vulnerable 
groups of subjects and consequently different types and 
distribution of brain lesions
7,11,13-15 
The NINDS-AIREN criteria
4 are the most widely used 
in randomised clinical trials. These criteria adequately 
(1) emphasise the heterogeneity of VaD syndromes and 
pathologic subtypes including not only ischaemic stroke 
but also other causes of CVD such as cerebral hypoxic- 
ischaemic events, white matter lesions (WMLs) and 
hemorrhagic strokes, (2) recognise the variability in 
clinical course, which may be static, remitting or 
progressive, (3) highlight the location of ischaemic 
lesions and the need to establish a causal relationship 
between vascular brain lesions and cognition, (4) 
recognise the need to establish a temporal relationship 
between stroke and dementia onset, (5) include specific 
findings early in the course that support a vascular rather 
than a degenerative cause, (6) emphasise the importance 
of brain imaging to support clinical findings, and (7) 
recognise the value of neuropsychological testing to 
document impairment in multiple cognitive domains. 
Thus the NINDS-AIREN criteria define VaD as a 
syndrome with different aetiologies and clinical manifes-
tations rather than a single entity. The recognition of 
subtypes are potentially important for clinical trials. 
These criteria also incorporate three different levels of 
certainty of clinical diagnosis, namely probable, possible 
and definite.
4 
In a previous neuropathological series, the sensitivity 
of the NINDS-AIREN criteria for probable and possible 
VaD was determined to be 58% and the specificity 
80%.
16 The criteria successfully excluded AD in 91% of 
cases, and the proportion of mixed cases misclassified as 
probable VaD was 29%. Interestingly, compared to the 
ADDTC criteria,
10 the NINDS-AIREN criteria were 
more specific and better in excluding mixed cases (54% 
vs. 29%). Despite these limitations, the frequencies of 
VaD in autopsy series have been reported to be as low 
as 0.03% and as high as 58% with an overall mean rate 
of 17%
17,18 that is consistent with estimates from clinical 
studies. In cases where currently accepted criteria have 
been applied the frequencies are even lower with a mean 
of 7%. Whereas the incidence of VaD cases in Japan 
was reported to be 35%
19 and 22%.
20 Taking these into 
account the worldwide frequency of VaD in autopsy 
verified cases might be estimated to be between 10 and 
15%. 
Clinical and pathological evidence indicates combined 
neurodegenerative and vascular pathologies worsen 
presentation and outcome of dementia.
21-24 A high 
proportion of individuals fulfilling the neuropathological 
diagnosis of AD have significant cerebrovascular lesions 
including silent infarcts upon imaging and extensive 
white matter disease.
25-28 Conversely, clinically diagnosed 
VaD patients frequently show extensive AD-type neuro-
pathological changes.
28-30 For example, in one study
31 
87% of the patients clinically diagnosed by NINDS- 
AIREN criteria were found to have AD either alone 
(58%) or in combination with cerebrovascular disease 
(42%) at post-mortem (Fig. 1). Hulette et al
30 noted that 
“pure” VaD is very uncommon because VaD cases 
without co-existing neuropathological evidence of AD 
are rarely found. Therefore current clinical diagnostic 
criteria serve to detect pathology but not “pure” 
pathology. Early validation studies indicated that while 
mixed dementia could be distinguished from AD, it 
could not be separated from VaD.
32 Recent studies 
suggest that 30-50% of mixed AD and VaD cases are 
misclassified as VaD
16,33 and the neuroimaging component 
of the NINDS-AIREN criteria does not distinguish 
between people with and without dementia in the 
context of cerebrovascular disease. The potential overlap 
of pathologies is therefore complex, with different types 
of cerebrovascular lesions including subcortical infarction 
and small vessel disease,
22,34 and accompanying neuro-
degenerative changes including tau, amyloid and α - 
synuclein pathology (Fig. 1). While evidence-based 
pathological criteria for the diagnosis of mixed dementia 
remains to be perfected, the diagnosis
35,36 should be 
made when a primary neurodegenerative disease known 
to cause dementia exists with one or more of the 
pathological lesions defining the VaD subtypes (Table 
1). The diagnosis of mixed dementia (AD and VaD or 
less frequently dementia with Lewy bodies and VaD) 
particularly among the oldest old (>85 years of age) Journal of Clinical Neurology: Vol. 2, No. 1, 2006
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∙Identify as ischaemic or haemorhagic infarct(s)
∙Presence of lacunes and lacunar infarcts: etat lacunaire (grey) 
and etat crible (WM)
∙Location of infarcts: WM, basal ganglia, brainstem (pontine)
∙Circulation involved: arterial territories- anterior, middle or 
posterior
∙Laterality: right or left anterior and posterior
∙Sizes and number of infarcts = dimension: 0-4 mm, 5-15 
mm, 16-30 mm, 31-50 mm and >50 mm; if size <5 mm 
determine as small or microinfarcts. 
∙Presence and location of small vessel disease: lipohyalinosis; 
fibroid necrosis; CAA
∙Presence of white matter disease: rarefaction or incomplete 
infarction
∙Degree of gliosis: mild, moderate or severe
∙Presence of Alzheimer pathology (incl. NFT and neuritic 
plaque staging). If degree >stage III the case is mixed AD 
and VaD
∙Presence of hippocampal sclerosis
For reporting purposes each of above features can be scored 
numerically to provide a summary. For example, 0 is absent 
and 1 means present. Less frequent lesions including watershed 
infarcts and laminar necrosis. Increasing numerical value may 
also be assigned to the infarcts. 
CAA, cerebral amyloid angiopathy; NFT, neurofibrillary tangles; 
WM, white matter.
Table 2. Key variables to define pathology of SV Dementia
therefore also remains a challenge.
TYPES OF LESIONS IN VaD
Atherothromboembolism may be responsible for up to 
50% of all ischaemic strokes involving both cortical and 
subcortical infarctions. Intracranial small vessel disease 
causes 25% of the infarcts.
37 Small vessel alternations 
involve arteriosclerosis, hyalionsis and are associated 
with lacunar infarcts and lacunes predominantly 
occurring in the subcortical structures. White matter 
disease or subcortical leukoencephalopathy with 
incomplete infarction and small vessel disease are 
common pathological changes in cerebrovascular 
disease. Others features include borderzone (watershed) 
infarctions, laminar necrosis and amyloid angiopathy 
(Table 2). Complicated angiopathies such as fibro-
muscular dysplasia, arterial dissections, granulomatous 
angiitis, collagen vascular disease and giant-cell arteritis 
are rarer causes of cerebrovascular disease
37 and VaD. 
Previous studies have recorded ischaemic, oedematous 
and haemorrhagic lesions affecting the brain circulation 
or perfusion to be associated with VaD (Table 3). In 
four studies where VaD was diagnosed 75% of the cases 
revealed cortical and subcortical infarcts suggesting other 
vascular pathologies involving incomplete infarction or 
borderzone infarcts could be important factors. Among 
other lesions 25% of the cases had cystic infarcts 
whereas 50% of the cases had lacunar infarcts or 
microinfarcts. Lacunar infarcts, however, appear to be a 
common category of infarcts, and currently recognised 
as the most frequent cause of stroke (dissections, 
granulomatous angiitis, collagen vascular disease and 
giant-cell arteritis are rarer causes of cerebrovascular 
disease).
37 Severe amyloid angiopathy was present in 
10% of the cases. Most interestingly, in one study 55% 
of the cases revealed hippocampal atrophy.
38 Ischaemic 
vascular disease appears to correlate with widespread 
small ischaemic lesions distributed throughout the 
CNS.
38
Pathological feature % Cases
Complete infarctions (cortical and subcortical)
Lacunar infarcts (mostly WM and BG)
Small or microinfarcts
Cystic infarcts
Cerebral amyloid angiopathy
Intracerebral haemorrhages
Hippocampal atrophy and sclerosis
75%
50%
50%
25%
10%
 2%
55%
Data compiled from 70 cases reported in previous studies
22,30,34,38
(RN Kalaria et al., unpublished observations). % cases are 
averaged from 2 or more reported studies. Cystic infarcts 
(possibly also lacunar) with typically ragged edges were 
admixed in both cortical and subcortical structures. 
BG, basal ganglia; WM, white matter.
Table 3. Types of vascular and hippocampal lesions reported in
VaD Kalaria RN and Erkinjuntti T. Cerebral Small Vessel Disease 
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SUBTYPES OF VaD AND 
SUBCORTICAL VASCULAR SYNDROME
The main subtypes of VaD included in current 
classifications are cortical VaD or MID (also referred as 
post-stroke VaD) and subcortical vascular dementia 
(SVD) or small vessel disease related dementia.
4,39-42 
Strategic infarct dementia, hypoperfusive dementia 
resulting from global cerebrovascular insufficiency are 
less common types.
4,39,41,43 Further, subtypes include 
hemorrhagic dementia and hereditary vascular dementias. 
Cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leukoencephalopathy or CADASIL is 
probably the most common form of familial SVD. 
Not surprisingly, the clinical presentation of cortical 
and subcortical forms of VaD show remarkable 
differences. Large vessel occlusions resulting in large 
cortical infarcts produce cognitive and other deficits that 
depend on the location of the infarcts, while SVD may 
have a relatively characteristic neuropsychological profile 
that includes early impairment of attention and executive 
function, with slowing of motor performance and 
information processing.
2,3,44 
Clinically, SVD is characterised by pure motor 
hemiparesis, bulbar signs and dysarthria, gait disorder, 
variable depressive illness, emotional lability, and 
deficits in executive functioning.
45-49 The early clinical 
phase of SVD includes episodes of mild upper motor 
neuron signs (drift, reflex asymmetry, incordination), 
gait disorder (apractic-atactic or small-stepped), imba-
lance and falls, urinary frequency and incontinence, 
dysarthria, dysphagia as well as extrapyramidal signs 
such as hypokinesia and rigidity.
44,47,48,50 However, these 
focal neurological signs are often subtle.
51,52 Upon 
imaging patients with SVD have multiple lacunes and 
extensive WMLs and often reveal clinical history of 
“prolonged TIA” or “multiple TIAs” which mostly are 
small strokes without residual symptoms and only mild 
focal findings (e.g. drift, reflex asymmetry, gait distur-
bance). This supports the importance of neuroimaging 
requirements in the criteria.
44 
The early cognitive syndrome of SVD is characterized 
by a dysexecutive syndrome with slowed information 
processing, usually mild memory deficit and behavioural 
symptoms.
3 The dysexecutive syndrome includes 
impairment in goal formulation, initiation, planning, 
organising, sequencing, executing, set-shifting and set- 
maintenance, as well as in abstraction.
40,47,53 The 
memory deficit in SVD is usually milder than in AD, 
and is specified by impaired recall, relative intact 
recognition, less severe forgetting and better benefit 
from cues.
53 Episodic memory may be relatively spared, 
compared with AD. There is more learning impairment 
that can be partially corrected by providing salient cues 
to encourage learning and promote recognition.
54 
Therefore, memory deficits in VaD appear to be caused 
by problems in retrieval of information;
55-57 in turn, 
memory retrieval deficits are due to aberrant frontal and 
subcortical mechanisms. In contrast, in AD involvement 
of the hippocampus by neurofibrillary tangles (Braak 
Stage III) prevents storage of new information causing 
amnesic mild cognitive impairment. The SVD syndrome 
may be readily confused with AD in view of the 
neuronal loss and coexisting vascular factors. The onset 
can be variable as suggested previously.
45 Sixty percent 
of the patients had a slow, less abrupt onset, and only 
30% an acute onset of cognitive symptoms. The course 
was gradual without (40%) and with (40%) acute 
deficits, and fluctuating in only 20%.
45
Behavioural and psychological symptoms in SVD 
include depression, personality change, emotional lability, 
loss of volition (apathy),
42 incontinence, as well as inertia, 
emotional bluntness and psychomotor retardation.
4,40,47 
These may include greater tendencies of aggression and 
agitation.
2 Such symptomatology is attributed to damage 
to the prefrontal subcortical circuits.
44,58
PATHOLOGICAL LESIONS IN SVD
SVD incorporates two entities “the lacunar state” and 
“Binswanger’s disease.”
3 SVD is accredited to small 
vessel disease and is characterised by lacunar infarcts, 
focal and diffuse ischaemic WMLs, and incomplete 
ischaemic injury.
47-50,59 The infarcts and WMLs are 
expected consequences of small vessel disease. Small 
vessels including intracerebral end-arteries and arterioles Journal of Clinical Neurology: Vol. 2, No. 1, 2006
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Figure 2. Pathological lesions associated with small vessel 
disease. A small infarct (arrow) and lacunes (arrowhead) in the
basal ganglia of a 78 year old man with cognitive impairment. 
B and C, hyalinsed vessels with perivascular rarefaction and 
microinfarct in the white matter of a 78 year old man. Moderate
gliosis in the surrounding region is also evident in both cases. 
Magnification Bar: A=2 cm; B, C=50 µm.
undergo progressive age-related changes,
59,60 which may 
result in lacunar or microinfarcts. These range from wall 
thickening by hyalinosis, reduction or increment of the 
intima to severe arteriosclerosis and fibroid necrosis 
(Fig. 2). Uncomplicated hyalinosis is characterised by 
almost complete degeneration of vascular smooth muscle 
cells (becomes acellular) with concentric accumulation 
of extracellular matrix components like the collagens 
and fibroblasts.
60 These changes are most common in the 
small vasculature of the white matter (Fig. 2-B). Small 
vessel changes likely promote occlusion or progressive 
stenosis with consequent acute or chronic ischaemia of 
the tissue behind it.
60 Alternatively, arteriolsclerotic 
changes located in small vessels in the deep white 
matter and basal ganglia (lenticulostriate) may loose 
their elasticity to dilate and constrict in response to 
variations of systemic blood pressure or loss of 
auto-regulation. This in turn causes fluctuations in blood 
flow response and changes in cerebral perfusion. The 
deep cerebral structures would be rendered most 
vulnerable because the vessels are end arteries almost 
devoid of anastomoses. Small vessel pathology could 
lead also oedema and damage of the blood-brain barrier 
(BBB) with chronic leakage of fluid and macro-
molecules in the white matter.
61 
Lacunes as complete or cavitating infarcts as defined 
above, measuring up to 15 mm in diameter, are seen 
radiologically and upon gross examination at autopsy 
(Table 2; Fig. 2). These lesions are largely confined to 
the cerebral white matter and subcortical structures 
including the thalamus, basic ganglia and brainstem. 
Most lacunes, remnants of small infarcts, are detected in 
the cystic or chronic stage with no viable central tissue 
but could have perifocal regions with incomplete 
infarction, particularly in the white matter. A few 
lacunes may represent healed or re-absorbed as minute 
or petechial haemorrhages. Microlacunes have also been 
described which essentially should be thought of as large 
cystic microinfarcts. To distinguish perivascular cavities 
it has been suggested that lacunes be classed into three 
subtypes: lacunar infarcts, lacunar haemorrhages and 
dilated perivascular spaces.
63 Lacunar infarcts usually 
result from progressive small vessel disease manifested 
as hypertensive angiopathy that may involve stenosis 
caused by hyalinosis. Small vessel disease in a 
perforating artery for example, may also reveal regions 
of incomplete infarction, attenuation or rarefaction 
usually recognised by pallor upon microscopic exami-
nation. However, lacunar lesions can also be caused by 
infections and neoplasms. Lacunes are associated with 
small perivascular cavities up to 2 mm in diameter often 
found in the basal ganglia and the white matter.
59,61 
Perivascular cavities or empty spaces resulting from 
distortion or elongation of small arteries collectively 
referred to as état lacunaire in the grey matter and état 
crible in the white matter may be numerous in older 
subjects.
62
Microinfarcts have been variably described but widely 
thought to be small ishaemic lesions visible only upon 
light microscopy (Fig. 2-A and B). These lesions of up 
to 5 mm diameter may or may not involve a small 
vessel at its centre but are foci with pallor, neuronal 
loss, axonal damage (white matter) and gliosis. Some-
times these may include regions of incomplete infarction 
or rarefied (subacute) change. Microinfarcts have also 
been described as attenuated lesions of indistinct nature Kalaria RN and Erkinjuntti T. Cerebral Small Vessel Disease 
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occurring in both cortical or subcortical regions. 
Microinfarcts and lacunar infarcts appear central to the 
most common cause of VaD and predict poor outcome 
in the elderly.
37,38,63 Interestingly, in the autopsied older 
Japanese-American men the importance of microvascular 
lesions as a likely explanation for dementia was nearly 
equal to that of Alzheimer lesions.
64 Microinfarction in 
the subcortical structures has been emphasised as 
substrate of cognitive impairment, and correlated with 
increased Alzheimer type of pathology but cortical 
microinfarcts also appear to contribute to significantly to 
the progression of cognitive deficits in brain aging.
65 
Furthermore microinfarcts even in borderzone (water-
shed) regions may aggravate the degenerative process as 
indicated by worsening impairment in AD.
66 Thus 
multiple microinfarction appears strongly correlated with 
dementia indicated by several studies.
17
White matter lesions (or subcortical leucoencephalo-
pathy) incorporating myelin loss are considered a 
consequence of vascular disease. The frequency of white 
matter changes is increased in patients with cerebrovas-
cular disease and those at risk for vascular disease 
including arterial hypertension, cardiovascular disease 
and diabetes mellitus.
2 Lesions in the deep white matter 
have been correlated with dementia including VaD.
2,28 
Conflicting data with respect to periventricular lesions 
may depend on definition of the boundaries between the 
periventricular and deep white matter if the coursing of 
the fibres are used as markers. Lacunar infracts are 
produced when the ischaemic damage is focal and of 
sufficient severity to result in a small area of necrosis 
whereas diffuse white matter change is considered a 
form of rarefaction or incomplete infarction where there 
may be selective damage to some cellular components. 
While the U-fibres are usually spared white matter 
disease comprises several patterns of alterations including 
pallor or swelling of myelin, loss of oligodendrocytes, 
axons and myelin fibres, cavitations with or without 
presence of macrophages and areas of reactive 
astrogliosis,
61 where the astrocytic cytoplasm and cell 
processes may be visible with standard stains. Lesions in 
the white matter also include spongiosis i.e. vacuoli-
sation of the white matter structures and widening of the 
perivascular spaces.
Cerebral amyloid angiopathy (CAA) also falls in to 
the category of small vessel diseases and contributes to 
the SVD syndrome. Current evidence shows age rather 
than gender, history of hypertension or other vascular 
disease to be the strongest risk factor for sporadic 
occurrence of CAA.
67,68 Several familial forms of CAA 
presenting with ischaemic and haemorrhagic infarcts or 
oligaemia are perhaps the most studied among the 
hereditary cerebrovascular disorders.
69,70 The clinical 
features comprise focal neurological signs including 
spasticity, ataxia, facial paralysis, occasional seizures 
and cognitive impairment often leading to dementia.
71-73 
Consideration of the hereditary cerebral haemorrhage 
with amyloidosis of the Dutch type (HCHWA-D) 
disease provides certain clues to a link between CAA 
and stroke. It is thought that the first stroke-like episode 
triggers multiple cerebral bleeds which may be preceded 
by diffuse white matter changes that in turn lead to rapid 
decline of cognitive functions.
71,74 The degree of CAA is 
strongly correlated with the presence or absence of 
dementia while this was not true for diffuse plaques or 
neurofibrillary tangles. This suggests CAA alone causes 
dementia in HCHWA-D,
73 a notion likely to be the case 
in other hereditary amyloid angiopathies.
71 However, 
cognitive impairment is also a consistent feature in 
sporadic CAA cases in the absence of other pathologies 
as verified by MRI and neuropathological assessment.
69 
Ischaemic WMLs associated with lipohyalinosis and 
narrowing of the lumen of the small perforating arteries 
and arterioles, which nourish the deep white matter, 
often occur in AD and are common in VaD. Upon MRI 
these correspond best with deep with matter hyper-
intensities, which may increases the likelihood of correct 
diagnosis.
69 In a few studies biopsy proven CAA was 
associated with extensive diffuse hyperintensities 
presenting as multifocal non-haemorrhagic leukoariosis.
67,71 
Pathological studies also supported the robust relation-
ship between CAA and WMLs irrespective of the 
presence of Alzheimer type of pathology.
75,76
CADASIL AND HEREDITARY SMALL 
VESSEL DEMENTIA Journal of Clinical Neurology: Vol. 2, No. 1, 2006
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Several early reports suggest the existence of several 
familial stroke disorders unrelated to atherosclerotic 
disease. Most of these disorders may be classed as SVD 
involving small vessels of the subcortical structures.
77 
CADASIL is perhaps the most common form of these 
hereditary CVDs leading to cognitive decline and 
dementia.
78-81 It is difficult to estimate the world-wide 
prevalence of CADASIL but in western countries 
CADASIL cases occur ~5 in 100,000. There are 
estimated to be at least 500 CADASIL families 
worldwide suggesting that this disorder is much more 
common than familial AD.
77 CADASIL begins with 
migraine as the first symptom in up to 40% of the 
patients.
38,78,79 The age of onset is usually ascribed by 
the age at which the first ever stroke occurs rather than 
the migraine attack. CADASIL may be manifest well 
before the first stroke on the basis of characteristic white 
matter hyperintensities upon MRI.
82,83 Migraine usually 
with aura may begin even before the age of 10 years, 
but more commonly during the third decade.
38,79 More 
severe manifestations including TIAs, recurrent strokes 
and depressive illness follow quickly. Motor deficits, an 
ataxic hemiparesis, hemianopsia and dysarthria may 
accompany these principal events. Other features include 
seizures, incomplete cerebellar ataxia, pseudobulbar 
palsy and unexplained coma. Neocortical strokes are rare 
and they usually do not cover a wide territory.
83 Large 
artery infarcts such as those of the middle or posterior 
cerebral artery are uncommon.
77 Dichgans and 
colleagues
80 have suggested that the men are at greater 
risk for early immobilisation and death. However, 
smoking and high homocysteine (>15 µmol/l) can 
increase risk for more strokes and migraine.
81 There is 
not a clear consensus for genotype-phenotype correla-
tions
80 and the apolipoprotein E ε4 allele does not 
influence disease progression
81 (RK et al, unpublished 
observations). 
Pathological features include severe arteriopathy with 
the presence of granular osmiophilic material in the 
arterial walls of both the brain and systemic organs.
84 
Loss of brain vascular smooth muscle cells leads to wall 
thickening and fibrosis in small and medium-sized 
penetrating arteries.
77,84 This would reduce both cerebral 
blood flow and blood volume in affected white matter 
with effects on the haemodynamic reserve by decreasing 
the vasodilatory response. Affected vessels presumably 
progress to obliteration or thrombose as evident by the 
appearance of lacunar infarcts, mainly in the basal 
ganglia and fronto-temporal white matter.
84 These 
pathologies initiate cognitive deficits, which progress to 
dementia of the subcortical vascular type. 
CADASIL is caused by single missense mutations or 
exon deletions in the Notch 3 gene.
85 The gene encodes 
a type 1 transmembrane protein (Notch 3), which is 
essential during development and regulating cellular 
differentiation. In adults Notch 3 appears to be expressed 
only in vascular smooth muscle cells and may promote 
cell survival by inhibiting apoptosis but the exact 
function remains to be elucidated.
77 Notch 3 mutations 
consistently result in either a gain or loss of one (or 
more odd number of) cysteine residue(s) in one of the 
34 epidermal growth factor-like repeats in the amino- 
terminal region of the molecule.
85 It is not entirely clear 
which step in the Notch signalling pathway leads to the 
charactersitic vascular pathology of CADASIL. The 
clinical diagnosis of CADASIL is relied upon positive 
family history and hyperintense lesions upon T2 MRI 
particularly in the temporal pole, whereas confirmed by 
Notch 3 gene screening or the presence of GOM in skin 
or nerve-muscle biopsies.
77 
CONCLUSIONS
The heterogeneous nature of cerebrovascular disease 
compels better understanding of VaD presentation and 
prevalence. The two main subtypes of the VaD 
syndrome include large cortical infarction or MID and 
SVD or small vessel disease related dementia. SVD is 
clinically characterised by pure motor hemiparesis, 
bulbar signs and dysarthria, gait disorder, variable 
depressive illness, emotional lability, and deficits in 
executive functioning. The pathological features of SVD 
involve small vessel degeneration, lacunes, multiple 
microinfarcts in the subcortical structures and white 
matter lesions extending into the deep white matter. 
CADASIL is an example of familial SVD that presents 
with recurrent subcortical strokes and slowly progressing Kalaria RN and Erkinjuntti T. Cerebral Small Vessel Disease 
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course leading to cognitive impairment and dementia. 
The SVD syndrome may be readily confused with AD 
in view of the neuronal loss and coexisting vascular 
factors. However, the symptomatology in SVD is 
attributed to damage to the frontal- subcortical neuronal 
circuits.
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